Blog March 09
March 13th 09
New Report From Arthritis Research Campaign On Effectiveness Of Complementary Medicines
I am often asked about the effectiveness of various supplements in reducing joint pain. Well Arthritis Research Campaign (ARC) have produced a high quality report into the effectiveness of many complementary medicines – covering substances taken orally and topically.This is a summary of existing published studies which indicates whether or not there is scientific evidence to support the clinical effectiveness and safety of certain named products for people with arthritis
The report covers 40 different supplements for osteoarthritis, rheumatoid arthritis and fibromyalgia. Some of the more significant points are as follows:
Glucosamine sulphate scores only a 3 out of 5 for osteoarthritis. Given the number of people using and recommending glucosamine sulphate, coupled with a lot of anecdotal evidence I am surprised that it is not scored more highly.
The highest score for osteoarthritis is 5 out of 5 for capsaicin gel. This is a topically applied gel/herbal medicine extracted from chile pepper. Available on prescription (why do we need government to tell us how to use chile pepper?)
The highest score for rheumatoid arthritis is 5 out of 5 for fish body oil. This is a dietary supplement derived from tissues of fatty fish like sardines, sprat, salmon, and mackerel. Note this is not
cod liver oil which only received 1 out of 5 when tested on patients with osteoarthritis.
Phytodolor scored a respectable 4 out of 5 for osteoarthritis sufferers. Phytodolor is a German herbal preparation consisting of three medicinal extracts: aspen (Populus tremula), common ash bark (Franxinus excelsior) and golden rob herb (Solidago vigaurea).
SAMe also scored a respectable 4 out of 5 for osteoarthritis sufferers. This is described as a nutritional supplement and is a chemical compound derived from two acids: methionine, an amino acid also found in protein-rich foods; and adenosine triphosphate (ATP), a nucleic acid and the end-point of all energy gaining reactions in the human body. SAMe was discovered in 1952 and was first studied as a possible treatment for depression
For full details of the report please visit ARC